Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov
Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted t...
Gespeichert in:
Veröffentlicht in: | Brazilian journal of microbiology 2015-07, Vol.46 (3), p.861-865 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 865 |
---|---|
container_issue | 3 |
container_start_page | 861 |
container_title | Brazilian journal of microbiology |
container_volume | 46 |
creator | Visnuvinayagam, Sivam Thangavel, K Lalitha, N Malmarugan, S Sukumar, Kuppannan |
description | Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds. |
doi_str_mv | 10.1590/S1517-838246320140051 |
format | Article |
fullrecord | <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S1517_83822015000300861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1517_83822015000300861</scielo_id><sourcerecordid>1717482833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</originalsourceid><addsrcrecordid>eNpdUctu1DAUtRCIlsIngCKxYZNy_XY2SFUFBVHBAthiOfFNx1UmHmxnUP--HqaMBla27HPuPQ9CXlI4p7KDt9-opLo13DChOAMqACR9RE6p0qYVAuTjo_sJeZbzLQCTINhTcsKUoBw0PSU_L3LGnNc4lyaOTVlhs3FlFW9wDkMod7vHAaepHZapLAlb592moG--4O_B5TJh40NGl7HZhrTkJpfkwtx8jmuX4vY5eTK6KeOLh_OM_Pjw_vvlx_b669Wny4vrdhDalFZ3nUZPR9UJ0XsD3ism-KgN9qgG2VOJDlD1mnE_cq2kkcLVFLR0DJTw_Iyc7-fmIeAU7W1c0lwX2j8x2V1MNSMJABzAKFoJ7_aEzdKv0Q_Vf3KT3aRQdd_Z6IL992cOK3sTt1ZIZfYD3jwMSPHXgrnYdci7pNyMccmWaqqFYYbzCn39H_Qgj2pQVEvDuoqSe9SQYs4Jx4MYCnZX-ZGXo8or79WxkwPrb8f8Hm7xpXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706175829</pqid></control><display><type>article</type><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</creator><creatorcontrib>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</creatorcontrib><description>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</description><identifier>ISSN: 1678-4405</identifier><identifier>ISSN: 1517-8382</identifier><identifier>EISSN: 1678-4405</identifier><identifier>DOI: 10.1590/S1517-838246320140051</identifier><identifier>PMID: 26413071</identifier><language>eng</language><publisher>Brazil: Springer Nature B.V</publisher><subject>Animal diseases ; Animals ; Cell Culture Techniques ; Cells, Cultured ; Chick Embryo ; Chickens - immunology ; Chickens - virology ; MICROBIOLOGY ; Newcastle disease virus - classification ; Newcastle disease virus - growth & development ; Newcastle disease virus - pathogenicity ; Poultry ; Poultry Diseases - immunology ; Poultry Diseases - prevention & control ; Poultry Diseases - virology ; Primary Cell Culture ; Vaccination ; Vaccines ; Vaccines, Attenuated - adverse effects ; Vaccines, Attenuated - immunology ; Vaccines, Attenuated - therapeutic use ; Veterinary Microbiology ; Viral Vaccines - adverse effects ; Viral Vaccines - immunology ; Viral Vaccines - therapeutic use ; Viruses</subject><ispartof>Brazilian journal of microbiology, 2015-07, Vol.46 (3), p.861-865</ispartof><rights>Copyright Sociedade Brasileira de Microbiologia 2015</rights><rights>Copyright © 2015, Sociedade Brasileira de Microbiologia 2015</rights><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26413071$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Visnuvinayagam, Sivam</creatorcontrib><creatorcontrib>Thangavel, K</creatorcontrib><creatorcontrib>Lalitha, N</creatorcontrib><creatorcontrib>Malmarugan, S</creatorcontrib><creatorcontrib>Sukumar, Kuppannan</creatorcontrib><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><title>Brazilian journal of microbiology</title><addtitle>Braz J Microbiol</addtitle><description>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</description><subject>Animal diseases</subject><subject>Animals</subject><subject>Cell Culture Techniques</subject><subject>Cells, Cultured</subject><subject>Chick Embryo</subject><subject>Chickens - immunology</subject><subject>Chickens - virology</subject><subject>MICROBIOLOGY</subject><subject>Newcastle disease virus - classification</subject><subject>Newcastle disease virus - growth & development</subject><subject>Newcastle disease virus - pathogenicity</subject><subject>Poultry</subject><subject>Poultry Diseases - immunology</subject><subject>Poultry Diseases - prevention & control</subject><subject>Poultry Diseases - virology</subject><subject>Primary Cell Culture</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated - adverse effects</subject><subject>Vaccines, Attenuated - immunology</subject><subject>Vaccines, Attenuated - therapeutic use</subject><subject>Veterinary Microbiology</subject><subject>Viral Vaccines - adverse effects</subject><subject>Viral Vaccines - immunology</subject><subject>Viral Vaccines - therapeutic use</subject><subject>Viruses</subject><issn>1678-4405</issn><issn>1517-8382</issn><issn>1678-4405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdUctu1DAUtRCIlsIngCKxYZNy_XY2SFUFBVHBAthiOfFNx1UmHmxnUP--HqaMBla27HPuPQ9CXlI4p7KDt9-opLo13DChOAMqACR9RE6p0qYVAuTjo_sJeZbzLQCTINhTcsKUoBw0PSU_L3LGnNc4lyaOTVlhs3FlFW9wDkMod7vHAaepHZapLAlb592moG--4O_B5TJh40NGl7HZhrTkJpfkwtx8jmuX4vY5eTK6KeOLh_OM_Pjw_vvlx_b669Wny4vrdhDalFZ3nUZPR9UJ0XsD3ism-KgN9qgG2VOJDlD1mnE_cq2kkcLVFLR0DJTw_Iyc7-fmIeAU7W1c0lwX2j8x2V1MNSMJABzAKFoJ7_aEzdKv0Q_Vf3KT3aRQdd_Z6IL992cOK3sTt1ZIZfYD3jwMSPHXgrnYdci7pNyMccmWaqqFYYbzCn39H_Qgj2pQVEvDuoqSe9SQYs4Jx4MYCnZX-ZGXo8or79WxkwPrb8f8Hm7xpXU</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Visnuvinayagam, Sivam</creator><creator>Thangavel, K</creator><creator>Lalitha, N</creator><creator>Malmarugan, S</creator><creator>Sukumar, Kuppannan</creator><general>Springer Nature B.V</general><general>Sociedade Brasileira de Microbiologia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CLZPN</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>GPN</scope></search><sort><creationdate>20150701</creationdate><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><author>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animal diseases</topic><topic>Animals</topic><topic>Cell Culture Techniques</topic><topic>Cells, Cultured</topic><topic>Chick Embryo</topic><topic>Chickens - immunology</topic><topic>Chickens - virology</topic><topic>MICROBIOLOGY</topic><topic>Newcastle disease virus - classification</topic><topic>Newcastle disease virus - growth & development</topic><topic>Newcastle disease virus - pathogenicity</topic><topic>Poultry</topic><topic>Poultry Diseases - immunology</topic><topic>Poultry Diseases - prevention & control</topic><topic>Poultry Diseases - virology</topic><topic>Primary Cell Culture</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated - adverse effects</topic><topic>Vaccines, Attenuated - immunology</topic><topic>Vaccines, Attenuated - therapeutic use</topic><topic>Veterinary Microbiology</topic><topic>Viral Vaccines - adverse effects</topic><topic>Viral Vaccines - immunology</topic><topic>Viral Vaccines - therapeutic use</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Visnuvinayagam, Sivam</creatorcontrib><creatorcontrib>Thangavel, K</creatorcontrib><creatorcontrib>Lalitha, N</creatorcontrib><creatorcontrib>Malmarugan, S</creatorcontrib><creatorcontrib>Sukumar, Kuppannan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Latin America & Iberia Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><jtitle>Brazilian journal of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Visnuvinayagam, Sivam</au><au>Thangavel, K</au><au>Lalitha, N</au><au>Malmarugan, S</au><au>Sukumar, Kuppannan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</atitle><jtitle>Brazilian journal of microbiology</jtitle><addtitle>Braz J Microbiol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>46</volume><issue>3</issue><spage>861</spage><epage>865</epage><pages>861-865</pages><issn>1678-4405</issn><issn>1517-8382</issn><eissn>1678-4405</eissn><abstract>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</abstract><cop>Brazil</cop><pub>Springer Nature B.V</pub><pmid>26413071</pmid><doi>10.1590/S1517-838246320140051</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1678-4405 |
ispartof | Brazilian journal of microbiology, 2015-07, Vol.46 (3), p.861-865 |
issn | 1678-4405 1517-8382 1678-4405 |
language | eng |
recordid | cdi_scielo_journals_S1517_83822015000300861 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Animal diseases Animals Cell Culture Techniques Cells, Cultured Chick Embryo Chickens - immunology Chickens - virology MICROBIOLOGY Newcastle disease virus - classification Newcastle disease virus - growth & development Newcastle disease virus - pathogenicity Poultry Poultry Diseases - immunology Poultry Diseases - prevention & control Poultry Diseases - virology Primary Cell Culture Vaccination Vaccines Vaccines, Attenuated - adverse effects Vaccines, Attenuated - immunology Vaccines, Attenuated - therapeutic use Veterinary Microbiology Viral Vaccines - adverse effects Viral Vaccines - immunology Viral Vaccines - therapeutic use Viruses |
title | Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20pathogenicity%20of%20cell-culture-adapted%20Newcastle%20disease%20virus%20strain%20Komarov&rft.jtitle=Brazilian%20journal%20of%20microbiology&rft.au=Visnuvinayagam,%20Sivam&rft.date=2015-07-01&rft.volume=46&rft.issue=3&rft.spage=861&rft.epage=865&rft.pages=861-865&rft.issn=1678-4405&rft.eissn=1678-4405&rft_id=info:doi/10.1590/S1517-838246320140051&rft_dat=%3Cproquest_sciel%3E1717482833%3C/proquest_sciel%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706175829&rft_id=info:pmid/26413071&rft_scielo_id=S1517_83822015000300861&rfr_iscdi=true |